United States Dialysis Market Insights Forecasts to 2033

• The United States Dialysis Market Size was valued at USD 26.55 Billion in 2023.
• The Market Size is Growing at a CAGR of 4.1% from 2023 to 2033.
• The United States Dialysis Market Size is Expected to Reach USD 39.69 Billion by 2033.

The United States Dialysis Market Size is Expected to Reach USD 39.69 Billion by 2033, at a CAGR of 4.1% during the forecast period 2023 to 2033.

Market Overview

Dialysis is a medical procedure that filters and purifies the blood of patients whose kidneys no longer function properly. It is a critical treatment option for people with end-stage renal disease or advanced kidney disease. Dialysis can be performed in two ways: hemodialysis and peritoneal dialysis. Hemodialysis uses a machine to filter blood outside the body, whereas peritoneal dialysis uses the lining of the abdomen as a filter. The dialysis market in the United States is an important part of the healthcare industry because it helps manage kidney-related conditions. Dialysis is a life-saving treatment for people suffering from end-stage renal disease (ESRD) or chronic kidney failure. It aids in the removal of waste products and excess fluids from the blood when the kidneys are unable to perform these functions properly. Technological advancements and innovation are aid to grow United States dialysis market over the forecast period. There are numerous opportunities for companies to invest in R&D to improve dialysis technology and treatment outcomes.

Report Coverage

This research report categorizes the market for United States dialysis market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States dialysis market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the United States dialysis market.

Driving Factors

Shift from clinics to home healthcare services driving the United States dialysis market growth during forecast period. Many patients with end-stage renal disease (ESRD) switch from one type of dialysis to another based on their routine. Some patients prefer to treat themselves at home, while others prefer to see professionals in clinics. It can be done in a specialized facility or at home. However, patients are increasingly shifting from clinics to home healthcare because they can dialyze from the comfort of their own homes. Home hemodialysis has potential advantages over clinics and hospitals. Patients can schedule more frequent and longer sessions. The use of home healthcare services helps to deal with the growing number of people who require treatment. The increasing prevalence of end-stage renal disease (ESRD) is driving up demand for dialysis services in the United States. the market is expected to grow even more as the patient pool expands.

Restraining Factors

Dialysis treatment can be costly, especially for the uninsured or underinsured, limiting access to adequate care. In addition, the scarcity of available donor organs for kidney transplantation fuels the demand for dialysis as an alternative treatment method. Also, many people are unaware of the early signs and symptoms of kidney disease, resulting in delayed diagnosis and treatment. Moreover, dialysis can cause complications and side effects such as infection, fluid imbalances, and cardiovascular problems, which may discourage some patients from seeking treatment.

Market Segment

• In 2023, the hemodialysis segment accounted for the largest revenue share over the forecast period.

Based on the type, the United States dialysis market is segmented into hemodialysis and peritoneal dialysis. Among these, the hemodialysis segment has the largest revenue share over the forecast period. This segment is further classified as acute and chronic. The rise in hypertension and diabetes rates has contributed to segmental dominance. According to the centers for disease control and prevention (CDC), the prevalence of diabetes in the United States is expected to be more than 34 million. Furthermore, factors such as a shortage of kidneys for transplantation are likely to boost United States dialysis market growth.

• In 2023, the services segment accounted for the largest revenue share over the forecast period.

Based on the product & Service, the United States dialysis market is segmented into equipment, consumables, and services. Among these, the services segment has the largest revenue share over the forecast period. The increasing availability of dialysis in homes and clinics has increased demand for such services among patients. As more people choose dialysis, there will be a greater demand for medical supplies. Many industry manufacturers are focusing on developing cutting-edge dialysis equipment to help to grow U.S dialysis market.

• In 2023, the in-center dialysis segment accounted for the largest revenue share over the forecast period.

Based on the end use, the United States dialysis market is segmented into in-center dialysis and home dialysis. Among these, the in-center dialysis segment has the largest revenue share over the forecast period. Patients treated at these centers can relax and interact with other patients and staff, which improves the effectiveness of their treatment and overall health. Another factor contributing to in-center dialysis therapy's increasing popularity is the availability of trained renal care professionals who provide the best service possible. Furthermore, treatment and patient assessment are performed in the same location, which increases adoption, hence it is driving segmental growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States dialysis market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Nipro Corporation
• Asahi Kasei Corporation
• U.S. Renal Care, Inc.
• B. Braun Melsungen AG, DaVita Inc.
• Becto
• Dickinson and Company
• Medtronic plc
• Fresenius Medical Care AG & Co.
• American Renal Associates
• Sanderling Renal Services
• Toray Industries Inc.
• Baxter International Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In June 2021, DaVita Care Connect, a mobile health platform designed specifically for those receiving home dialysis, now offers virtual support groups to patients. This virtual assistance system was designed to allow the company to connect with a large number of patients receiving treatment at home while expanding its customer base.

Market Segment

This study forecasts country revenue from 2022 to 2033. Spherical Insights has segmented the United States dialysis market based on the below-mentioned segments:

United States Dialysis Market, By Type

• Hemodialysis
• Peritoneal Dialysis

United States Dialysis Market, By Product & Service      

• Equipment
• Consumables
• Services

United States Dialysis Market, By End Use

• In-center Dialysis
• Home Dialysis